Each year millions of patients worldwide are potential candidates for non-invasive radiosurgery.​

Yet with the costs and complexities of historical SRS delivery, only an estimated 200,000 receive treatment.



The ZAP-X® Gyroscopic Radiosurgery® platform opens new frontiers in modern surgical robotics, bringing state-of-the-art cranial SRS to more patients in more places, and expanding world-class care to locations previously considered inconceivable.

European Radiosurgery Center
Munich, Germany

As the first-in-kind “self-shielded” radiosurgery system, ZAP-X eliminates the need for high-cost radiation bunkers.*

Enabling simple department expansions, ZAP-X also makes cost-effective SRS feasible in virtually any location—including suburban and rural satellites, as well as innovative outpatient settings.

Using state-of-the-art linear accelerator technology, ZAP-X enables diverse non-coplanar radiation delivery while eliminating the historical need for live radioactive sources. No more costly source replacements. No more regulatory bureaucracy.

And as access to Co-60 becomes increasingly scarce, ZAP-X future-proofs your SRS investment.

ZAP-X is dedicated to world-class cranial radiosurgery without the quality trade-offs associated with multi-purpose, full-body radiotherapy systems.

Leveraging a unique dual independent gantry design, ZAP-X aims to maximally protect neurocognitive function and preserve the option for future potential SRS re-treatments.

With Purpose. With passion.

As the creator of the first new dedicated radiosurgery platform in nearly half a century, ZAP enables neurosurgeons and radiation oncologists to change precision radiation medicine for the better.

Founded in 2014 by John R. Adler, Jr., MD, renowned Stanford neurosurgeon and inventor of the CyberKnife®, ZAP strives to define the future of radiosurgery through better technology and new potential clinical applications.

Recent News

First ZAP-X Gyroscopic Radiosurgery Platform Installation in Poland
University Hospital in Olsztyn Becomes the First Site in Eastern Europe to Offer the Latest Advance in Non-Invasive Brain Tumor Treatment
The Institut du Cancer Courlancy to Acquire ZAP-X Radiosurgery Platform
Site to be among Europe’s first to offer groundbreaking innovation in non-invasive treatment for brain tumors
Neurosurgery One in Littleton, Colorado Treats First Patient with ZAP-X
Access to Brain Tumor Treatment Gets Major Boost in Rocky Mountain Region
Chairman of Foxconn Technology Joins Board of Directors
Appointment Demonstrates Foxconn and ZAP Co-Founder Terry Gou’s Commitment to Accelerated Commercialization of ZAP-X Non-Invasive Brain Tumor Treatment Platform

Everyone Benefits

Patient preparing for treatment with ZAP-X


When treating the brain, the tools cannot be too refined. As a surgical alternative for select cranial indications, ZAP-X offers patients the latest technological advances in radiosurgery.

As a painless outpatient procedure with no incision, and often no recovery period, patients typically return to normal activities the same day as treatment.

Group of physicians from European Radiosurgery Center in Munich Germany, surrounding a ZAP-X


Putting patients first, ZAP-X aspires to set new standards in care through a ground-up design dedicated to cranial SRS – without the design compromises necessary for multi-purpose systems to treat breast, lung, and prostate cancers.

The goal: best-in-class dosimetry with an exceptionally low non-therapeutic dose to the healthy brain and body.

Exterior of Swiss Clinical Neuroscience Institute


Build a distinguished clinical brand with ZAP-X, a preeminent technology proven to yield significant publication, presentation, and media interest.

And by blending lower facility and operating costs with well-established reimbursement, ZAP-X introduces a new standard in cost-effective, high-quality care.

See for Yourself.
Let us show you how ZAP-X can treat more patients in more places. Speak to a representative today.
European Radiosurgery Center
Munich, Germany

Pushing the Boundaries of Surgical Robots.